CDW’s share price fell to its lowest point in the past year on the latest trading session, registering a new 52-week trough on unusually light turnover of just over 160,000 shares. This follows a modest pullback from recent moving-average resistance, with the 50-day average near 144 and the 200-day average around 159. The drop underscores growing caution among traders as the business cycles in key end markets remain uncertain.

Since late October, five major brokerages have revised their forecasts on CDW. Evercore ISI reduced its objective by roughly 7% while upholding an outperform view; Barclays cut its target by about 16% but stayed at equal-weight; UBS pared its forecast by 5% with a buy recommendation; Weiss Ratings left its hold grade unchanged; and Raymond James raised its outlook to strong-buy despite assigning a target nearly 10% below its previous estimate. Collectively, the consensus implies upside of around 38% from current levels, reflecting a “Moderate Buy” stance.

In the November quarter, CDW delivered earnings per share of 2.71, topping the analyst consensus by nine cents, while revenue of 5.74 billion narrowly trailed estimates by a few million. Net margin held at 4.76% and return on equity reached a robust 51.9%. Management reiterated its full-year EPS forecast of approximately 9.4, suggesting confidence in service-contract renewals and enterprise spending patterns.

The firm’s balance sheet shows a quick ratio of 1.30, current ratio of 1.39 and a debt-to-equity ratio of 2.21, supporting a quarterly dividend of 0.63 per share for a 1.9% yield and a payout ratio near 32%. This marks a decade of consecutive dividend increases. Meanwhile, an insider sold roughly 7,400 shares in early December, trimming their holding by about 21%—the first material reduction by senior management this year, and insiders now own just under 1% of total shares outstanding.